AzTrials
AzTrials

Inguinal HerniasTEP-CATNCT07886814

Urinary Catheterization Versus No Catheterization in Laparoscopic Total Extraperitoneal Inguinal Hernia Repair

A study testing Routine Urinary Catheterization and No Routine Urinary Catheterization in people with Inguinal Hernias, run by Ugur Duman at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this randomized controlled clinical trial is to determine whether avoiding routine urinary catheterization reduces postoperative urinary symptoms in patients undergoing laparoscopic totally extraperitoneal (TEP) inguinal hernia repair. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Inguinal Hernias
What is being tested?
Routine Urinary Catheterization and No Routine Urinary Catheterization
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Mar 2026to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age 18 years or older.
  • Clinical or radiological diagnosis of inguinal hernia.
  • Scheduled to undergo laparoscopic totally extraperitoneal (TEP) inguinal hernia repair.

Who cannot join

  • Scrotal inguinal hernia.
  • Prolapsed inguinal hernia.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Bursa Yuksek Ihtisas Training and Research Hospital

    Bursa, 16310

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Routine Urinary Catheterization on Postoperative Urinary Symptoms and Complications Following Laparoscopic Total Extraperitoneal Inguinal Hernia Repair: A Prospective Randomized Controlled Trial

The goal of this randomized controlled clinical trial is to determine whether avoiding routine urinary catheterization reduces postoperative urinary symptoms in patients undergoing laparoscopic totally extraperitoneal (TEP) inguinal hernia repair.

The main questions it aims to answer are:

Read more
  • Does avoiding routine urinary catheterization reduce the incidence of dysuria on postoperative day 1?
  • Does avoiding routine urinary catheterization reduce postoperative urinary or urethral pain without increasing urinary retention or other complications? Researchers will compare patients undergoing laparoscopic TEP inguinal hernia repair with routine urinary catheterization to those undergoing the same procedure without urinary catheterization.

Participants will:

  • Undergo laparoscopic TEP inguinal hernia repair with or without routine urinary catheterization according to randomized group assignment.
  • Complete postoperative assessments of urinary symptoms and complications on days 1, 10, and 30.
  • Undergo follow-up for inguinal hernia recurrence for six months after surgery.
Read the detailed description

Routine urinary catheterization is commonly performed during laparoscopic totally extraperitoneal (TEP) inguinal hernia repair to maintain bladder decompression and facilitate preperitoneal dissection. However, catheter placement may cause postoperative urinary discomfort and urethral irritation. The clinical necessity of routine catheterization during TEP repair remains uncertain.

This prospective, single-center, randomized controlled trial was designed to evaluate the effects of routine urinary catheterization on postoperative urinary symptoms and surgical safety.

All procedures were performed under general anesthesia by a single surgeon with 24 years of surgical experience. A standardized laparoscopic TEP technique was used in both groups. The preperitoneal working space was established using balloon dissection, followed by identification and dissection of the hernia sac and exposure of the myopectineal orifice. A polypropylene mesh was placed to cover the myopectineal orifice, with limited fixation. Hemostasis was confirmed, and no surgical drains were routinely placed.

In the catheterization group, the urinary catheter was maintained throughout the immediate postoperative period and removed before discharge, approximately 24 hours after surgery. Patients in the no-catheterization group underwent the same surgical procedure without routine urinary catheter placement.

Postoperative urinary symptoms were evaluated through patient-reported assessments and clinical follow-up. Urinary or urethral pain intensity was measured using a 0-10 visual analog scale (VAS), with higher scores indicating greater pain intensity.

The study was designed to assess whether omission of routine urinary catheterization could improve postoperative patient comfort while maintaining the safety of laparoscopic TEP inguinal hernia repair.

Being tested
Routine Urinary Catheterization, No Routine Urinary Catheterization
Keywords
Urinary Catheterization, Laparoscopic Inguinal Hernia Repair, Total Extraperitoneal Repair, Postoperative Dysuria, Urethral Pain, Randomized Controlled Trial
Medical subject headings
Hernia, Inguinal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Routine Urinary CatheterizationProcedure or surgery

    Routine perioperative urinary catheterization was performed in participants undergoing laparoscopic total extraperitoneal inguinal hernia repair. The urinary catheter was maintained during the immediate postoperative period and removed before hospital discharge, approximately 24 hours after surgery.

  • No Routine Urinary CatheterizationProcedure or surgery

    Participants underwent laparoscopic total extraperitoneal inguinal hernia repair without routine perioperative urinary catheter placement. Postoperative urinary symptoms and urinary retention were assessed using the same follow-up schedule as the catheterization group.

Study groups in NCT07886814
Study groupRoleWhat they receive
No Urinary CatheterizationExperimentalParticipants assigned to this group underwent laparoscopic total extraperitoneal (TEP) inguinal hernia repair without routine perioperative urinary catheterization. The surgical procedure was performed under general anesthesia using a standardized technique. Postoperative urinary symptoms, urinary retention, and surgical complications were assessed during follow-up.
Receives: Procedure: No Routine Urinary Catheterization
Routine Urinary CatheterizationActive comparatorParticipants assigned to this group underwent laparoscopic totally extraperitoneal (TEP) inguinal hernia repair with routine perioperative urinary catheterization. A urinary catheter was placed during the perioperative period and removed before hospital discharge, approximately 24 hours after surgery. Postoperative urinary symptoms, urinary retention, and surgical complications were assessed during follow-up.
Receives: Procedure: Routine Urinary Catheterization

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of Dysuria on Postoperative Day 1

    The primary outcome was the incidence of postoperative dysuria, defined as patient-reported pain, burning, or discomfort during urination within the first 24 hours following laparoscopic total extraperitoneal inguinal hernia repair. Dysuria was assessed as a binary outcome (present or absent). The proportion of participants experiencing dysuria was compared between the urinary catheterization and no-catheterization groups.

    Measured: Postoperative Day 1 (within 24 hours after surgery)

Secondary outcomes (10)
  1. Incidence of Urinary or Urethral Pain on Postoperative Day 1

    The presence of urinary or urethral pain was assessed on postoperative day 1 using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain). Pain was considered present when the VAS score was greater than 0. The proportion of participants reporting pain was compared between the two study groups.

    Measured: Postoperative Day 1 (within 24 hours after surgery)

  2. Incidence of Urinary or Urethral Pain on Postoperative Day 10

    Urinary or urethral pain was assessed on postoperative day 10 using a 0-10 visual analog scale (VAS). Pain was classified as present when the VAS score was greater than 0. The incidence of pain was compared between the urinary catheterization and no-catheterization groups.

    Measured: Postoperative Day 10

  3. Incidence of Urinary or Urethral Pain on Postoperative Day 30

    Urinary or urethral pain was assessed on postoperative day 30 using a visual analog scale (VAS) ranging from 0 to 10. Pain was defined as a VAS score greater than 0. The proportion of participants reporting pain was evaluated in each intervention group.

    Measured: Postoperative Day 30

  4. Urinary or Urethral Pain Severity on Postoperative Day 1

    The severity of urinary or urethral pain was assessed using an 11-point visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores were compared between the urinary catheterization and no-catheterization groups.

    Measured: Postoperative Day 1

  5. Urinary or Urethral Pain Severity on Postoperative Day 10

    Urinary or urethral pain intensity was measured using a 0-10 visual analog scale (VAS) on postoperative day 10. Higher scores indicated greater pain intensity.

    Measured: Postoperative Day 10

  6. Urinary or Urethral Pain Severity on Postoperative Day 30

    Urinary or urethral pain intensity was evaluated on postoperative day 30 using a visual analog scale (VAS) ranging from 0 (no pain) to 10 (worst imaginable pain).

    Measured: Postoperative Day 30

  7. Incidence of Urinary or Urethral Pain During the First 30 Postoperative Days

    The composite incidence of postoperative urinary or urethral pain was defined as the presence of pain (VAS score greater than 0) at any of the scheduled postoperative assessments on days 1, 10, or 30. Participants reporting pain at least once during the follow-up period were classified as having experienced urinary or urethral pain. The proportion of affected participants was compared between the two groups.

    Measured: Postoperative Days 1, 10, and 30

  8. Incidence of Postoperative Urinary Retention

    Postoperative urinary retention was assessed during postoperative follow-up. The incidence of urinary retention was recorded as a binary outcome (present or absent), and the proportion of affected participants was compared between the urinary catheterization and no-catheterization groups.

    Measured: Within 30 days after surgery

  9. Incidence of Postoperative Complications

    Postoperative complications were assessed during the first 30 days after laparoscopic TEP inguinal hernia repair. Recorded complications included urinary retention, scrotal emphysema, and scrotal ecchymosis. The proportion of participants experiencing at least one postoperative complication was compared between the intervention groups.

    Measured: Within 30 days after surgery

  10. Incidence of Inguinal Hernia Recurrence Within Six Months

    Hernia recurrence was assessed during a six-month postoperative follow-up period. Recurrence was defined as the reappearance of an inguinal hernia following laparoscopic TEP repair, as identified through postoperative clinical evaluation. The proportion of participants experiencing recurrence was compared between the two intervention groups.

    Measured: Up to 6 months after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2026
  2. Study start1 Mar 2026
  3. Primary completion1 Jun 2026
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
This was a prospective, single-center, two-arm, parallel-group randomized controlled trial. Participants undergoing laparoscopic total extraperitoneal (TEP) inguinal hernia repair were randomly assigned using a lottery-based allocation method to either routine urinary catheterization or no urinary catheterization. Both groups underwent the same standardized surgical procedure, and postoperative urinary outcomes were assessed at predefined follow-up intervals.
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07886814
Sponsor's protocol ID
2024-TBEK 2026/02-16
Acronym
TEP-CAT
Status last verified
Oct 2026
First submitted
15 Oct 2026
Last updated
23 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be made publicly available due to patient confidentiality considerations and the absence of a predefined individual participant data-sharing plan in the study protocol.

Questions about this trial

What is this clinical trial studying?

A study testing Routine Urinary Catheterization and No Routine Urinary Catheterization in people with Inguinal Hernias, run by Ugur Duman at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 23 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of Dysuria on Postoperative Day 1 (time frame: Postoperative Day 1 (within 24 hours after surgery)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Oct 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in